Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of remimazolam + remifentanil for sedation during laryngoscopy with laryngeal mask airway in middle-aged and elderly patients
ChiCTR2400081360Phase 4Not yet recruiting
- Sponsor
- Shunde Hospital, Southern Medical University
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in bronchopulmonary diseases (2 arms), sponsored by Shunde Hospital, Southern Medical University. Primary endpoints: Heart rate, Blood pressure and 1 more. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2400081360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081360.